Alert Added Successfully

Endocrinology


               
Article Title Year Authour(s) Journal Subject Expert Rating Evidence Ranking
1. Aberrant Phex function in osteoblasts and osteocytes alone underlies murine X-linked hypophosphatemia 2008 Yuan, B..., Takaiwa, M..., Clemens, T...L... J Clin Invest Endocrinology B
2. α-Klotho as a Regulator of Calcium Homeostasis 2007 Imura, A..., Tsuji, Y..., Murata, M... Science Endocrinology D
3. Long-term Proton Pump Inhibitor Therapy and Risk of Hip Fracture 2006 Yang, Y...-.X..., Lewis, J...D..., Epstein, S... JAMA Endocrinology B
4. Loss of Ubiquitin-Binding Associated With Paget's Disease of Bone p62 (SQSTM1) Mutations 2005 Cavey, J.R., Ralston, S.H., Hocking, L.J. J Bone Miner Res Endocrinology B
5. Lrp5 Controls Bone Formation by Inhibiting Serotonin Synthesis in the Duodenum 2008 Yadav, V...K..., Ryu, J...H..., Suda, N... Cell Endocrinology A
6. High-Trauma Fractures and Low Bone Mineral Density in Older Women and Men 2007 Mackey, D...C..., for the Study of Osteoporotic Fractures (SOF) and Osteoporotic Fractures in Men Study (MrOS) Research Groups. JAMA Endocrinology B
7. Effects of Conjugated Equine Estrogen on Risk of Fractures and BMD in Postmenopausal Women With Hysterectomy: Results From the Women's Health Initiative Randomized Trial 2006 Jackson, R.D. J Bone Miner Res Endocrinology A
8. Surgery or Surveillance for Mild Asymptomatic Primary Hyperparathyroidism: A Prospective, Randomized Clinical Trial 2007 Ambrogini, E..., Cetani, F..., Cianferotti, L... J Clin Endocrinol Metab Endocrinology A
9. Cinacalcet Reduces Serum Calcium Concentrations in Patients with Intractable Primary Hyperparathyroidism 2009 Marcocci, C..., Chanson, P..., Shoback, D... J Clin Endocrinol Metab Endocrinology B
10. L-Arginine, the Natural Precursor of NO, Is Not Effective for Preventing Bone Loss in Postmenopausal Women 2005 Baecker, N., Boese, A., Schoenau, E. J Bone Miner Res Endocrinology B
11. Zoledronic Acid and Clinical Fractures and Mortality after Hip Fracture 2007 Lyles, K...W..., for the HORIZON Recurrent Fracture Trial. N Engl J Med Endocrinology A
12. Lasofoxifene in Postmenopausal Women with Osteoporosis 2010 Cummings, S...R..., Ensrud, K..., Delmas, P...D... N Engl J Med Endocrinology A
13. Effect of Once-Weekly Oral Alendronate on Bone Loss in Men Receiving Androgen Deprivation Therapy for Prostate Cancer: A Randomized Trial 2007 Greenspan, S...L..., Nelson, J...B..., Trump, D...L... Ann Intern Med Endocrinology E
14. Effects of Teriparatide Versus Alendronate for Treating Glucocorticoid-Induced Osteoporosis: Thirty-Six–Month Results of a Randomized, Double-Blind, Controlled Trial 2009 Saag, K...G..., Zanchetta, J...R..., Devogelaer, J...-.P... Arthritis Rheum Endocrinology A
15. Effects of Teriparatide, Alendronate, or Both on Bone Turnover in Osteoporotic Men 2006 Finkelstein, J.S., Leder, B.Z., Burnett, S.A.M. J Clin Endocrinol Metab Endocrinology A
16. Regulation of Bone Turnover by Sex Steroids in Men 2008 Sanyal, A..., Hoey, K...A..., Mödder, U...I... J Bone Miner Res Endocrinology B
17. Effect of Recombinant Human Parathyroid Hormone (1-84) on Vertebral Fracture and Bone Mineral Density in Postmenopausal Women with Osteoporosis: A Randomized Trial 2007 Greenspan, S...L..., for the Treatment of Osteoporosis with Parathyroid Hormone Study Group. Ann Intern Med Endocrinology A
18. The Antiresorptive Effects of a Single Dose of Zoledronate Persist for Two Years: A Randomized, Placebo-Controlled Trial in Osteopenic Postmenopausal Women 2009 Grey, A..., Bolland, M...J..., Wattie, D... J Clin Endocrinol Metab Endocrinology B
19. Low Vitamin D Status despite Abundant Sun Exposure 2007 Binkley, N..., Novotny, R..., Krueger, D... J Clin Endocrinol Metab Endocrinology B
20. Relationship Between Low Bone Mineral Density and Exercise-Induced Myocardial Ischemia 2007 From, A...M..., Hyder, J...A..., Kearns, A...E... Mayo Clin Proc Endocrinology B
21. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis 2007 Tang, B...M...P..., Eslick, G...D..., Nowson, C... Lancet Endocrinology A
22. Coincidence of Multiple Endocrine Neoplasia Types 1 and 2: Mutations in the RET Protooncogene and MEN1 Tumor Suppressor Gene in a Family Presenting With Recurrent Primary Hyperparathyroidism 2005 Frank-Raue, K., Rondot, S., Hoeppner, W. J Clin Endocrinol Metab Endocrinology B
23. Continuous PTH and PTHrP Infusion Causes Suppression of Bone Formation and Discordant Effects on 1,25(OH)2 Vitamin D 2005 Horwitz, M.J., Tedesco, M.B., Sereika, S.M. J Bone Miner Res Endocrinology B
24. IFN-γ stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation 2007 Gao, Y..., Grassi, F..., Ryan, M...R... J Clin Invest Endocrinology D
25. Does Reduced Skeletal Loading Account for Age-Related Bone Loss? 2006 Melton, L...J.. III., Riggs, B...L..., Achenbach, S...J... J Bone Miner Res Endocrinology B
26. Calcium plus Vitamin D Supplementation and the Risk of Fractures 2006 Jackson, R.D. N Engl J Med Endocrinology A
27. Normocalcemic Primary Hyperparathyroidism: Further Characterization of a New Clinical Phenotype 2007 Lowe, H..., McMahon, D...J..., Rubin, M...R... J Clin Endocrinol Metab Endocrinology B
28. Alendronate for the Treatment of Osteopenia in Anorexia Nervosa: A Randomized, Double-blind, Placebo-controlled Trial 2005 Golden, N.H., Iglesias, E.A., Jacobson, M.S. J Clin Endocrinol Metab Endocrinology A
29. Biochemical Markers of Bone Turnover, Hip Bone Loss, and Fracture in Older Men: The MrOS Study 2009 Bauer, D...C..., Garnero, P..., Harrison, S...L... J Bone Miner Res Endocrinology A
30. Prevention of Bone Loss in Survivors of Breast Cancer: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial 2007 Greenspan, S...L..., Bhattacharya, R...K..., Sereika, S...M... J Clin Endocrinol Metab Endocrinology A
31. Chronic Elevation of Parathyroid Hormone in Mice Reduces Expression of Sclerostin by Osteocytes: A Novel Mechanism for Hormonal Control of Osteoblastogenesis 2005 Bellido, T., Ali, A.A., Gubrij, I. Endocrinology Endocrinology E
32. Cinacalcet Treatment of Primary Hyperparathyroidism: Biochemical and Bone Densitometric Outcomes in a Five-Year Study 2009 Peacock, M..., Bolognese, M...A..., Borofsky, M... J Clin Endocrinol Metab Endocrinology A
33. Osteocalcin Expression by Circulating Endothelial Progenitor Cells in Patients With Coronary Atherosclerosis 2008 Gössl, M..., Mödder, U...I..., Atkinson, E...J... J Am Coll Cardiol Endocrinology B
34. Low bone mineral density and fracture burden in postmenopausal women 2007 Cranney, A..., Jamal, S...A..., Tsang, J...F... Can Med Assoc J Endocrinology B
35. Bone mineral density loss and recovery during 48 months in first-time users of depot medroxyprogesterone acetate 2006 Clark, M...K..., Sowers, M..., Levy, B... Fertil Steril Endocrinology B
36. SLC34A3 Mutations in Patients with Hereditary Hypophosphatemic Rickets with Hypercalciuria Predict a Key Role for the Sodium-Phosphate Cotransporter NaPi-IIc in Maintaining Phosphate Homeostasis 2006 Bergwitz, C., Roslin, N.M., Tieder, M. Am J Hum Genet Endocrinology B
37. Mutation of the sequestosome 1 (p62) gene increases osteoclastogenesis but does not induce Paget disease 2007 Kurihara, N..., Hiruma, Y..., Zhou, H... J Clin Invest Endocrinology D
38. Primary cilia mediate mechanosensing in bone cells by a calcium-independent mechanism 2007 Malone, A...M...D..., Anderson, C...T..., Tummala, P... Proc Natl Acad Sci U S A Endocrinology D
39. Osteoporosis in Adult Survivors of Adolescent Cardiac Transplantation May Be Related to Hyperparathyroidism, Mild Renal Insufficiency, and Increased Bone Turnover 2005 Cohen, A., Addonizio, L.J., Lamour, J.M. J Heart Lung Transplant Endocrinology B
40. Pseudohypoparathyroidism and GNAS Epigenetic Defects: Clinical Evaluation of Albright Hereditary Osteodystrophy and Molecular Analysis in 40 Patients 2010 Mantovani, G..., de Sanctis, L..., Barbieri, A...M... J Clin Endocrinol Metab Endocrinology B
41. Calcineurin regulates bone formation by the osteoblast 2005 Sun, L., Blair, H.C., Peng, Y. Proc Natl Acad Sci U S A Endocrinology E
42. Teriparatide or Alendronate in Glucocorticoid-Induced Osteoporosis 2007 Saag, K...G..., Shane, E..., Boonen, S... N Engl J Med Endocrinology A
43. Cortical and Trabecular Load Sharing in the Human Vertebral Body 2006 Eswaran, S.K., Gupta, A., Adams, M.F. J Bone Miner Res Endocrinology B
44. Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial 2009 Reid, D...M..., for the HORIZON investigators. Lancet Endocrinology A
45. Relationship of Volumetric BMD and Structural Parameters at Different Skeletal Sites to Sex Steroid Levels in Men 2005 Khosla, S., Melton, L.J III., Robb, R.A. J Bone Miner Res Endocrinology B
46. Risk Factors for Fracture in Nonosteoporotic Men and Women 2007 Nguyen, N...D..., Eisman, J...A..., Center, J...R... J Clin Endocrinol Metab Endocrinology B
47. Effect of Cholecalciferol Plus Calcium on Falling in Ambulatory Older Men and Women: A 3-Year Randomized Controlled Trial 2006 Bischoff-Ferrari, H.A., Orav, E.J., Dawson-Hughes, B. Arch Intern Med Endocrinology A
48. Efficacy and safety of balloon kyphoplasty compared with non-surgical care for vertebral compression fracture (FREE): a randomised controlled trial 2009 Wardlaw, D..., Cummings, S...R..., Van Meirhaeghe, J... Lancet Endocrinology A
49. Circulating Fibroblast Growth Factor 23 in Patients with End-Stage Renal Disease Treated by Peritoneal Dialysis is Intact and Biologically Active 2010 Shimada, T..., Urakawa, I..., Isakova, T... J Clin Endocrinol Metab Endocrinology B
50. Hereditary Hypophosphatemic Rickets with Hypercalciuria Is Caused by Mutations in the Sodium-Phosphate Cotransporter Gene SLC34A3 2006 Lorenz-Depiereux, B., Benet-Pages, A., Eckstein, G. Am J Hum Genet Endocrinology E
51. Paget's Disease of Bone: Histologic Analysis of 754 Patients 2009 Seitz, S..., Priemel, M..., Zustin, J... J Bone Miner Res Endocrinology B
52. Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis 2009 Cummings, S...R..., for the FREEDOM Trial. N Engl J Med Endocrinology A
53. Primary cilia mediate mechanosensing in bone cells by a calcium-independent mechanism 2007 Malone, A...M...D..., Anderson, C...T..., Tummala, P... Proc Natl Acad Sci U S A Endocrinology D
54. α-Klotho as a Regulator of Calcium Homeostasis 2007 Imura, A..., Tsuji, Y..., Murata, M... Science Endocrinology D
55. Daily and Cyclic Parathyroid Hormone in Women Receiving Alendronate 2005 Cosman, F., Nieves, J., Zion, M. N Engl J Med Endocrinology A
56. Prevalence and Trends in Low Femur Bone Density Among Older US Adults: NHANES 2005–2006 Compared With NHANES III 2010 Looker, A...C..., Melton, L...J.. III., Harris, T...B... J Bone Miner Res Endocrinology B
57. Morbidity and Mortality Associated With Paget's Disease of Bone: A Population-Based Study 2008 Wermers, R...A..., Tiegs, R...D..., Atkinson, E...J... J Bone Miner Res Endocrinology B
58. Effects of Oral Alendronate on BMD in Adult Patients With Osteogenesis Imperfecta: A 3-Year Randomized Placebo-Controlled Trial 2006 Chevrel, G., Schott, A.M., Fontanges, E. J Bone Miner Res Endocrinology A
59. Surgery or Surveillance for Mild Asymptomatic Primary Hyperparathyroidism: A Prospective, Randomized Clinical Trial 2007 Ambrogini, E..., Cetani, F..., Cianferotti, L... J Clin Endocrinol Metab Endocrinology A
60. Population-Based Analysis of the Relationship of Whole Bone Strength Indices and Fall-Related Loads to Age- and Sex-Specific Patterns of Hip and Wrist Fractures 2006 Riggs, B.L., Melton, L.J III., Robb, R.A. J Bone Miner Res Endocrinology B
61. Sex-Specific and Non-Sex-Specific Quantitative Trait Loci Contribute to Normal Variation in Bone Mineral Density in Men 2005 Peacock, M., Koller, D.L., Fishburn, T. J Clin Endocrinol Metab Endocrinology B
62. Factors Associated With 5-Year Risk of Hip Fracture in Postmenopausal Women 2007 Robbins, J..., Aragaki, A...K..., Kooperberg, C... JAMA Endocrinology B
63. Efficacy of Bazedoxifene in Reducing New Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis: Results From a 3-Year, Randomized, Placebo-, and Active-Controlled Clinical Trial 2008 Silverman, S...L..., Christiansen, C..., Genant, H...K... J Bone Miner Res Endocrinology A
64. Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis 2007 Black, D...M..., for the HORIZON Pivotal Fracture Trial. N Engl J Med Endocrinology A
65. Hypophosphatemia Leads to Rickets by Impairing Caspase-Mediated Ap-optosis of Hypertrophic Chondrocytes 2005 Sabbagh, Y., Carpenter, T.O., Demay, M.B. Proc Natl Acad Sci USA Endocrinology B
66. Systematic Review: Biphosphonates and Osteonecrosis of the Jaws 2006 Woo, S.B., Hellstein, J.W., Kalmar, J.R. Ann Intern Med Endocrinology E
67. Early Responsiveness of Women with Osteoporosis to Teriparatide After Therapy with Alendronate or Risedronate 2008 Miller, P...D..., Delmas, P...D..., Lindsay, R... J Clin Endocrinol Metab Endocrinology B
68. Low Bone Mass and High Bone Turnover in Postmenopausal Human Immunodeficiency Virus-Infected Women 2010 Yin, M...T..., McMahon, D...J..., Ferris, D...C... J Clin Endocrinol Metab Endocrinology B
69. Effect of Recombinant Human Parathyroid Hormone (1-84) on Vertebral Fracture and Bone Mineral Density in Postmenopausal Women with Osteoporosis: A Randomized Trial 2007 Greenspan, S...L..., for the Treatment of Osteoporosis with Parathyroid Hormone Study Group. Ann Intern Med Endocrinology A
70. Relationship Between Serum Parathyroid Hormone Levels, Vitamin D Sufficiency, and Calcium Intake 2005 Steingrimsdottir, L., Gunnarsson, O., Indridason, O.S. JAMA Endocrinology B
71. Older Men With Low Serum Estradiol and High Serum SHBG Have an Increased Risk of Fractures 2008 Mellström, D..., Vandenput, L..., Mallmin, H... J Bone Miner Res Endocrinology B
72. Low Vitamin D Status despite Abundant Sun Exposure 2007 Binkley, N..., Novotny, R..., Krueger, D... J Clin Endocrinol Metab Endocrinology B
73. Thiazolidenedione Use and the Longitudinal Risk of Fractures in Patients with Type 2 Diabetes Mellitus 2010 Habib, Z...A..., Havstad, S...L..., Wells, K... J Clin Endocrinol Metab Endocrinology B
74. Early Changes in Biochemical Markers of Bone Formation Predict BMD Response to Teriparatide in Postmenopausal Women With Osteoporosis 2005 Chen, P., Satterwhite, J.H., Licata, A.A. J Bone Miner Res Endocrinology A
75. A Population-Based Assessment of Rates of Bone Loss at Multiple Skeletal Sites: Evidence for Substantial Trabecular Bone Loss in Young Adult Women and Men 2008 Riggs, B...L..., Melton, L...J.. III., Robb, R...A... J Bone Miner Res Endocrinology A
76. Comparison of a Single Infusion of Zoledronic Acid With Risedronate for Paget's Disease 2005 Reid, I.R., Miller, P., Lyles, K. N Engl J Med Endocrinology A
77. Frequency and Risk Factors Associated With Osteonecrosis of the Jaw in Cancer Patients Treated With Intravenous Bisphosphonates 2008 Hoff, A...O..., Toth, B...B..., Altundag, K... J Bone Miner Res Endocrinology B
78. Randomized Trial of Intensive Bisphosphonate Treatment Versus Symptomatic Management in Paget's Disease of Bone 2010 Langston, A...L..., Campbell, M...K..., Fraser, W...D... J Bone Miner Res Endocrinology B
79. Incidence of Primary Hyperparathyroidism in Rochester, Minnesota, 1993–2001: An Update on the Changing Epidemiology of the Disease 2006 Wermers, R.A., Khosla, S., Atkinson, E.J. J Bone Miner Res Endocrinology B
80. Effects of Teriparatide Treatment and Discontinuation in Postmenopausal Women and Eugonadal Men with Osteoporosis 2009 Leder, B...Z..., Neer, R...M..., Wyland, J...J... J Clin Endocrinol Metab Endocrinology B
81. IFN-γ stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation 2007 Gao, Y..., Grassi, F..., Ryan, M...R... J Clin Invest Endocrinology D
82. Normocalcemic Primary Hyperparathyroidism: Further Characterization of a New Clinical Phenotype 2007 Lowe, H..., McMahon, D...J..., Rubin, M...R... J Clin Endocrinol Metab Endocrinology B
83. Racial Differences in Rate of Decline in Bone Mass in Older Men: The Baltimore Men's Osteoporosis Study 2005 Tracy, J.K., Meyer, W.A., Flores, R.H. J Bone Miner Res Endocrinology B
84. Dynamic and Structural Properties of the Skeleton in Hypoparathyroidism 2008 Rubin, M...R..., Dempster, D...W..., Zhou, H... J Bone Miner Res Endocrinology B
85. Evaluation of MR spectroscopy and diffusion-weighted MRI in detecting bone marrow changes in postmenopausal women with osteoporosis 2010 Tang, G...Y..., Lv, Z...W..., Tang, R...B... Clin Radiol Endocrinology B
86. Effects of Yearly Zoledronic Acid 5mg on Bone Turnover Markers and Relation of PINP With Fracture Reduction in Postmenopausal Women With Osteoporosis 2009 Delmas, P...D..., Munoz, F..., Black, D...M... J Bone Miner Res Endocrinology A
87. A Novel Recessive Mutation in Fibroblast Growth Factor-23 Causes Familial Tumoral Calcinosis 2005 Larsson, T., Yu, X., Davis, S.I. J Clin Endocrinol Metab Endocrinology B
88. Denosumab in Postmenopausal Women with Low Bone Mineral Density 2006 McClung, M.R. N Engl J Med Endocrinology A
89. Comparison of the Effect of Denosumab and Alendronate on BMD and Biochemical Markers of Bone Turnover in Postmenopausal Women With Low Bone Mass: A Randomized, Blinded, Phase 3 Trial 2009 Brown, J...P..., Prince, R...L..., Deal, C... J Bone Miner Res Endocrinology A
90. Overexpression of Fibroblast Growth Factor 23 Suppresses Osteoblast Differentiation and Matrix Mineralization In Vitro 2008 Wang, H..., Yoshiko, Y..., Yamamoto, R... J Bone Miner Res Endocrinology B
91. Bone Mineralization Defects and Vitamin D Deficiency: Histomorphometric Analysis of Iliac Crest Bone Biopsies and Circulating 25-Hydroxyvitamin D in 675 Patients 2010 Priemel, M..., von Domarus, C..., Klatte, T...O... J Bone Miner Res Endocrinology B
92. Long-term Proton Pump Inhibitor Therapy and Risk of Hip Fracture 2006 Yang, Y...-.X..., Lewis, J...D..., Epstein, S... JAMA Endocrinology B
93. Low bone mineral density and fracture burden in postmenopausal women 2007 Cranney, A..., Jamal, S...A..., Tsang, J...F... Can Med Assoc J Endocrinology B
94. Hormonal and Biochemical Determinants of Trabecular Microstructure at the Ultradistal Radius in Women and Men 2006 Khosla, S., Melton, L.J III., Achenbach, S.J. J Clin Endocrinol Metab Endocrinology B
95. Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer 2009 Smith, M...R..., for the Denosumab HALT Prostate Cancer Study Group. N Engl J Med Endocrinology A
96. Primary Hyperparathyroidism and Osteosarcoma: Examination of a Large Cohort Identifies Three Cases of Fibroblastic Osteosarcoma 2005 Jimenez, C., Yang, Y., Kim, H.W. J Bone Miner Res Endocrinology B
97. Bone Marrow Changes in Adolescent Girls With Anorexia Nervosa 2009 Ecklund, K..., Vajapeyam, S..., Feldman, H...A... J Bone Miner Res Endocrinology B
98. Inhibiting Dickkopf-1 (Dkk1) Removes Suppression of Bone Formation and Prevents the Development of Osteolytic Bone Disease in Multiple Myeloma 2009 Heath, D...J..., Chantry, A...D..., Buckle, C...H... J Bone Miner Res Endocrinology B
99. Age-Dependent Demise of GNAS-Mutated Skeletal Stem Cells and "Normalization" of Fibrous Dysplasia of Bone 2008 Kuznetsov, S...A..., Cherman, N..., Riminucci, M... J Bone Miner Res Endocrinology B
100. Epidemiology of Paget's Disese in Europe: The Prevalence Is Decreasing 2006 Poór, G., Donáth, J., Fornet, B. J Bone Miner Res Endocrinology B
101. Comparative Effects of Teriparatide and Strontium Ranelate on Bone Biopsies and Biochemical Markers of Bone Turnover in Postmenopausal Women With Osteoporosis 2009 Recker, R...R..., Marin, F..., Ish-Shalom, S... J Bone Miner Res Endocrinology B
102. Effects of Continuing or Stopping Alendronate After 5 Years of Treatment: The Fracture Intervention Trial Long-Term Extension (FLEX): A Randomized Trial 2006 Black, D...M..., for the FLEX Research Group. JAMA Endocrinology B
103. Diabetes and Bone Loss at the Hip in Older Black and White Adults 2005 Schwartz, A.V., for the Health ABC Study. J Bone Miner Res Endocrinology B
104. High-Trauma Fractures and Low Bone Mineral Density in Older Women and Men 2007 Mackey, D...C..., for the Study of Osteoporotic Fractures (SOF) and Osteoporotic Fractures in Men Study (MrOS) Research Groups. JAMA Endocrinology B
105. Giant Osteoclast Formation and Long-Term Oral Bisphosphonate Therapy 2009 Weinstein, R...S..., Roberson, P...K..., Manolagas, S...C... N Engl J Med Endocrinology A
106. Effect of Rosiglitazone, Metformin, and Glyburide on Bone Biomarkers in Patients with Type 2 Diabetes 2010 Zinman, B..., Haffner, S...M..., Herman, W...H... J Clin Endocrinol Metab Endocrinology A
107. Combination Teriparatide and Raloxifene Therapy for Postmenopausal Osteoporosis: Results From a 6-Month Double-Blind Placebo-Controlled Trial 2005 Deal, C., Omizo, M., Schwartz, E.N. J Bone Miner Res Endocrinology A
108. Hip Fracture in Women Without Osteoporosis 2005 Wainwright, S.A., for the Study of Osteoporotic Fractures Research Group. J Clin Endocrinol Metab Endocrinology B
109. Effect of Once-Weekly Oral Alendronate on Bone Loss in Men Receiving Androgen Deprivation Therapy for Prostate Cancer: A Randomized Trial 2007 Greenspan, S...L..., Nelson, J...B..., Trump, D...L... Ann Intern Med Endocrinology E
110. Effects of Long-Term Strontium Ranelate Treatment on the Risk of Nonvertebral and Vertebral Fractures in Postmenopausal Osteoporosis: Results of a Five-Year, Randomized, Placebo-Controlled Trial 2008 Reginster, J.-.Y..., Felsenberg, D..., Boonen, S... Arthritis Rheum Endocrinology A
111. Serum 25-Hydroxyvitamin D Concentrations and Risk for Hip Fractures 2008 Cauley, J...A..., LaCroix, A...Z..., Wu, L... Ann Intern Med Endocrinology A
112. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis 2007 Tang, B...M...P..., Eslick, G...D..., Nowson, C... Lancet Endocrinology A
113. Altered Bone and Mineral Metabolism in Patients Receiving Imatinib Mesylate 2006 Berman, E., Nicolaides, M., Maki, R.G. N Engl J Med Endocrinology B
114. Risk Factors for Fracture in Nonosteoporotic Men and Women 2007 Nguyen, N...D..., Eisman, J...A..., Center, J...R... J Clin Endocrinol Metab Endocrinology B
115. The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs 2006 Kavanagh, K.L., Guo, K., Dunford, J.E. Proc Natl Acad Sci U S A Endocrinology E
116. Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial 2009 Reid, D...M..., for the HORIZON investigators. Lancet Endocrinology A
117. Monthly Oral Ibandronate Therapy in Postmenopausal Osteoporosis: 1-Year Results From the MOBILE Study 2005 Miller, P.D., McClung, M.R., Macovei, L. J Bone Miner Res Endocrinology A
118. Serum Dickkopf-1 is increased and correlates with reduced bone mineral density in patients with thalassemia-induced osteoporosis. Reduction post-zoledronic acid administration 2009 Voskaridou, E..., Christoulas, D..., Xirakia, C... Haematologica Endocrinology B
119. Does Reduced Skeletal Loading Account for Age-Related Bone Loss? 2006 Melton, L...J.. III., Riggs, B...L..., Achenbach, S...J... J Bone Miner Res Endocrinology B
120. Structural Determinants of Vertebral Fracture Risk 2007 Melton, L...J.. III., Riggs, B...L..., Keaveny, T...M... J Bone Miner Res Endocrinology B
121. Effects of Teriparatide and Alendronate on Vertebral Strength as Assessed by Finite Element Modeling of QCT Scans in Women With Osteoporosis 2007 Keaveny, T...M..., Donley, D...W..., Hoffmann, P...F... J Bone Miner Res Endocrinology B
122. Mutation of the sequestosome 1 (p62) gene increases osteoclastogenesis but does not induce Paget disease 2007 Kurihara, N..., Hiruma, Y..., Zhou, H... J Clin Invest Endocrinology D
123. One Year of Alendronate After One Year of Parathyroid Hormone (1–84) for Osteoporosis 2005 Black, D.M., for the PaTH Study Investigators. N Engl J Med Endocrinology A
124. Vitamin D status, parathyroid function, bone turnover, and BMD in postmenopausal women with osteoporosis: global perspective 2009 Kuchuk, N...O..., van Schoor, N...M..., Pluijm, S...M... J Bone Miner Res Endocrinology A
125. Short-Term Changes in Bone Turnover Markers and Bone Mineral Density Response to Parathyroid Hormone in Postmenopausal Women with Osteoporosis 2006 Bauer, D.C. J Clin Endocrinol Metab Endocrinology A
126. Low Bone Formation in Premenopausal Women With Idiopathic Osteoporosis 2005 Donovan, M.A., Dempster, D., Zhou, H. J Clin Endocrinol Metab Endocrinology B
127. Prevention of Bone Loss in Survivors of Breast Cancer: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial 2007 Greenspan, S...L..., Bhattacharya, R...K..., Sereika, S...M... J Clin Endocrinol Metab Endocrinology A
128. Strontium Ranelate Reduces the Risk of Vertebral and Nonvertebral Fractures in Women Eighty Years of Age and Older 2006 Seeman, E., Vellas, B., Benhamou, C. J Bone Miner Res Endocrinology A
129. Benefit of Adherence With Bisphosphonates Depends on Age and Fracture Type: Results From an Analysis of 101,038 New Bisphosphonate Users 2008 Curtis, J...R..., Westfall, A...O..., Cheng, H... J Bone Miner Res Endocrinology B
130. Bone mineral density loss and recovery during 48 months in first-time users of depot medroxyprogesterone acetate 2006 Clark, M...K..., Sowers, M..., Levy, B... Fertil Steril Endocrinology B
131. Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study 2006 Reginster, J.Y., Adami, S., Lakatos, P. Ann Rheum Dis Endocrinology A
132. Prevalence of Vitamin D Inadequacy Among Postmenopausal North American Women Receiving Osteoporosis Therapy 2005 Holick, M.F., Siris, E.S., Binkley, N. J Clin Endocrinol Metab Endocrinology B
133. Randomized Trial of Denosumab in Patients Receiving Adjuvant Aromatase Inhibitors for Nonmetastatic Breast Cancer 2008 Ellis, G...K..., Bone, H...G..., Chlebowski, R... J Clin Oncol Endocrinology A
134. Effects of Continuing or Stopping Alendronate After 5 Years of Treatment: The Fracture Intervention Trial Long-Term Extension (FLEX): A Randomized Trial 2006 Black, D...M..., for the FLEX Research Group. JAMA Endocrinology B
135. Strontium Ranelate Reduces the Risk of Nonvertebral Fractures in Postmenopausal Women With Osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) Study 2005 Reginster, J.Y., Seeman, E., DeVernejoul, M.C. J Clin Endocrinol Metab Endocrinology A
136. Structural Determinants of Vertebral Fracture Risk 2007 Melton, L...J.. III., Riggs, B...L..., Keaveny, T...M... J Bone Miner Res Endocrinology B
137. Relationship Between Low Bone Mineral Density and Exercise-Induced Myocardial Ischemia 2007 From, A...M..., Hyder, J...A..., Kearns, A...E... Mayo Clin Proc Endocrinology B
138. Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial 2009 Reid, D...M..., Devogelaer, J...-.P..., Saag, K... Lancet Endocrinology A
139. Factors Associated With 5-Year Risk of Hip Fracture in Postmenopausal Women 2007 Robbins, J..., Aragaki, A...K..., Kooperberg, C... JAMA Endocrinology B
140. Pretreatment Levels of Bone Turnover and the Antifracture Efficacy of Alendronate: The Fracture Intervention Trial 2006 Bauer, D.C. J Bone Miner Res Endocrinology A
141. Relationship Between Osteoporosis and Cardiovascular Disease in Post-menopausal Women 2005 Tankó, L.B., Christiansen, C., Cox, D.A. J Bone Miner Res Endocrinology B
142. Teriparatide or Alendronate in Glucocorticoid-Induced Osteoporosis 2007 Saag, K...G..., Shane, E..., Boonen, S... N Engl J Med Endocrinology A
143. A Randomized Trial of Vertebroplasty for Osteoporotic Spinal Fractures 2009 Kallmes, D...F..., Comstock, B...A..., Heagerty, P...J... N Engl J Med Endocrinology A
144. The Natural History of Primary Hyperparathyroidism with or without Parathyroid Surgery after 15 Years 2008 Rubin, M...R..., Bilezikian, J...P..., McMahon, D...J... J Clin Endocrinol Metab Endocrinology B
145. Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis 2007 Black, D...M..., for the HORIZON Pivotal Fracture Trial. N Engl J Med Endocrinology A
146. Zoledronic Acid and Clinical Fractures and Mortality after Hip Fracture 2007 Lyles, K...W..., for the HORIZON Recurrent Fracture Trial. N Engl J Med Endocrinology A
147. Vitamin D Metabolites and Calcium Absorption in Severe Vitamin D Deficiency 2008 Need, A...G..., O'Loughlin, P...D..., Morris, H...A... J Bone Miner Res Endocrinology B
148. Effects of Teriparatide in Postmenopausal Women with Osteoporosis on Prior Alendronate or Raloxifene: Differences between Stopping and Continuing the Antiresorptive Agent 2009 Cosman, F..., Wermers, R...A..., Recknor, C... J Clin Endocrinol Metab Endocrinology B
149. Comparison of Weekly Treatment of Postmenopausal Osteoporosis with Alendronate Versus Risedronate Over Two Years 2006 Bonnick, S. J Clin Endocrinol Metab Endocrinology A
150. Effects of Teriparatide and Alendronate on Vertebral Strength as Assessed by Finite Element Modeling of QCT Scans in Women With Osteoporosis 2007 Keaveny, T...M..., Donley, D...W..., Hoffmann, P...F... J Bone Miner Res Endocrinology B